doi:10.1001/jamacardio.2019.3780 Pimpley V, Patil S, Srinivasan K, Desai N, Murthy PS
First-line pharmacotherapy consists of glucagon-like peptide-1 (GLP-1) receptor agonists such as liraglutide (Saxenda) and semaglutide (Wegovy) delay gastric emptying, reduce hunger, and increase satiety, resulting in weight loss
Family History: Knowing if diseases like cancer run in the patients family can be valuable for diagnosis
Saxenda: Similarities and Differences Wegovy (semaglutide) and Saxenda (liraglutide) are two GLP-1 injectable drugs FDA-approved for long-term weight loss management
Zhang Y, Guo S, Wang S, Li X, Hou D, Li H, et al
Is oxidative damage the fundamental pathogenic mechanism of Alzheimers and other neurodegenerative diseases